Every Form 4 that Vicarious Surgical Inc (RBOT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RBOT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RBOT filings page.
Vicarious Surgical Inc. President and director Adam David Sachs reported an open-market sale of 942 shares of Class A Common Stock on February 20, 2026, at a weighted average price of $2.0878 per share. After this transaction, he held 46,943 shares directly.
The sale was executed under a mandated “sell to cover” arrangement to satisfy tax withholding obligations from vesting restricted stock units granted on May 19, 2022, and did not represent a discretionary trade by Sachs.
Vicarious Surgical Inc. director and Chief Technology Officer Sammy Khalifa reported an open-market sale of 754 shares of Class A common stock. The shares were sold at a weighted average price of $2.0841 per share, leaving 32,869 shares of Class A common stock held directly after the transaction.
According to the disclosure, this sale was executed solely to cover tax withholding obligations related to the vesting of restricted stock units granted on May 19, 2022, under the company’s equity incentive plan. The filing notes this was a mandated “sell to cover” transaction and not a discretionary trade by the reporting person.
Vicarious Surgical Inc. reported an insider share sale by a senior executive. On 12/03/2025, a reporting person who serves as Director, President and a 10% owner sold 463 shares of Class A common stock at a weighted average price of $2.952 per share. After this transaction, the insider directly beneficially owns 47,885 shares.
The company explains that the sale was executed solely to cover tax withholding obligations arising from the vesting of restricted stock units granted on June 2, 2023, under its equity incentive plan. The transaction was a mandatory “sell to cover” arrangement rather than a discretionary trade by the insider, and involved multiple trades at prices ranging from $2.715 to $3.34 per share.
Vicarious Surgical Inc. insider transaction: A reporting person who is a director, chief technology officer and 10% owner of Vicarious Surgical Inc. (RBOT) reported a small sale of Class A common stock. On 12/03/2025, the insider sold 239 shares of Class A common stock at a weighted average price of $2.97 per share, with individual trades ranging from $2.725 to $3.34 per share. After this transaction, the insider beneficially owns 33,623 shares directly. The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock units granted on June 2, 2023, under the company’s equity incentive plan and is described as a mandatory "sell to cover" rather than a discretionary trade.
Vicarious Surgical Inc. director and executive reports small share sale. A reporting person who is a director, 10% owner, and Chief Technology Officer of Vicarious Surgical Inc. (RBOT) reported selling 653 shares of Class A common stock on 11/20/2025 at a weighted average price of $2.744 per share. After this transaction, the reporting person beneficially owned 33,862 shares directly.
The company explains that the sale was carried out under its equity incentive plan to cover tax withholding obligations arising from the vesting of restricted stock units granted on May 19, 2022, and that it was a mandated "sell to cover" transaction rather than a discretionary trade.
Vicarious Surgical Inc. (RBOT) reported an insider transaction by a reporting person who is a director, president, and 10% owner. On 11/20/2025, the insider sold 816 shares of Class A common stock in a transaction coded “S”. The weighted average sale price was $2.715 per share, with individual trade prices ranging from $2.54 to $2.94 per share.
The filing explains that the sale was executed solely to cover tax withholding obligations arising from the vesting of restricted stock units granted on May 19, 2022, under the company’s equity incentive plan, and was not a discretionary trade. After this transaction, the insider beneficially owned 48,348 shares of Class A common stock.
Vicarious Surgical Inc. (RBOT) director Joseph Edward Doherty was granted a stock option on 06/27/2025 to buy 8,003 shares of Class A common stock at an exercise price of $7.61 per share. After the grant, the reporting person beneficially owns 8,003 shares tied to this option on a direct basis.
The option's underlying shares will vest on 06/27/2026 or one day prior to the issuer's next annual meeting of shareholders, whichever is earlier, subject to the reporting person's continued service. The Form 4 was signed by an attorney-in-fact on 10/02/2025.